Immunocore Holdings (IMCR) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
Immunocore Holdings insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 4 sold $5.6M of IMCR stock on the open market.
Get emailed when insiders cluster-buy stocks like IMCR
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
IMCR insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | — | 0 |
| Q2 2026 | — | 0 | — | 0 |
| Q1 2026 | — | 0 | $619K | 4 |
| Q4 2025 | — | 0 | $5.0M | 6 |
| Q3 2025 | — | 0 | $2.2M | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 Immunocore Holdings plc insiders reported open-market purchases totaling $0, while 4 insiders reported sales totaling $5.6M. 7 of 11 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Feb 19SEC | Bahija JallalCEO | Sell | 11,47412,343 held (−48%) | $32.35 | $371K | -9.1% | — |
| Feb 19SEC | David M BermanHead Of R&D | Sell | 5,9655,859 held (−50%) | $32.35 | $193K | -9.1% | — |
| Feb 19SEC | Leger Tina Amber StChief Hr Officer | Sell | 1,0001,119 held (−47%) | $32.35 | $32K | -9.1% | — |
| Feb 19SEC | John GollSvp, Finance & Cao | Sell | 698653 held (−52%) | $32.35 | $23K | -9.1% | — |
| Dec 8SEC | David M BermanHead Of R&D | Sell Plan | 31,341 | $40.26 | $1.3M | -27.0% | — |
| Dec 8SEC | David M BermanHead Of R&D | Sell Plan | 572 | $40.14 | $23K | -26.8% | — |
| Dec 1SEC | David M BermanHead Of R&D | Sell Plan | 69,404 | $40.12 | $2.8M | -26.7% | — |
| Dec 1SEC | David M BermanHead Of R&D | Sell Plan | 5,521 | $40.09 | $221K | -26.7% | — |
| Nov 26SEC | David M BermanHead Of R&D | Sell Plan | 18,020 | $40.03 | $721K | -26.6% | — |
| Nov 26SEC | David M BermanHead Of R&D | Sell Plan | 100 | $40.00 | $4K | -26.5% | — |
| Oct 2SEC | David M BermanHead Of R&D | Sell Plan | 61,849 | $35.23 | $2.2M | -16.6% | — |
Insiders at Immunocore Holdings plc
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| David M BermanHead Of R&D | — | $7.4M | Feb 19, 2026 | — |
| Bahija JallalCEO | — | $371K | Feb 19, 2026 | — |
| Leger Tina Amber StChief Hr Officer | — | $32K | Feb 19, 2026 | — |
| John GollSvp, Finance & Cao | — | $23K | Feb 19, 2026 | — |
IMCR stock: common questions
Are Immunocore Holdings plc insiders buying IMCR stock?
In the past 12 months, 0 insiders reported open-market purchases of IMCR worth $0.
Are Immunocore Holdings plc insiders selling IMCR stock?
4 insiders reported sales worth $5.6M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is IMCR's 52-week range?
Over the past year IMCR has traded between $27.79 and $40.22. It last closed at $29.39 on Oct 9, 2026.